Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event

Mitul D. Gandhi, Andrew M. Evens, Timothy S. Fenske, Paul Hamlin, Bertrand Coiffier, Andreas Engert, Alison J. Moskowitz, Nilanjan Ghosh, Adam M. Petrich, Jon Lomasney, Amy Chadburn, Gary S. Wood, Katrin Salva, Beatrice Nardone, Steven M. Trifilio, Dennis W. Raisch, Dennis P. West, Leo I. Gordon, Jane N. Winter*

*Corresponding author for this work

Research output: Contribution to journalLetter

36 Scopus citations
Original languageEnglish (US)
Pages (from-to)2895-2897
Number of pages3
JournalBlood
Volume123
Issue number18
DOIs
StatePublished - May 1 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Gandhi, M. D., Evens, A. M., Fenske, T. S., Hamlin, P., Coiffier, B., Engert, A., Moskowitz, A. J., Ghosh, N., Petrich, A. M., Lomasney, J., Chadburn, A., Wood, G. S., Salva, K., Nardone, B., Trifilio, S. M., Raisch, D. W., West, D. P., Gordon, L. I., & Winter, J. N. (2014). Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event. Blood, 123(18), 2895-2897. https://doi.org/10.1182/blood-2014-03-561878